The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
κ-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats
Open accessAbstract
Previously, it was shown that ethanol-dependent animals display increased sensitivity to the general opioid receptor antagonist nalmefene compared to naltrexone. It was hypothesized that the dissociable effects of the two antagonists were attributable to a κ-opioid receptor mechanism. Nucleus accumbens dynorphin is upregulated following chronic ethanol exposure and such neuroadaptations could contribute to nalmefene's increased potency in ethanol-dependent animals. To test this hypothesis, male Wistar rats were trained to self-administer ethanol using an operant conditioning procedure. Animals were then implanted with bilateral intra-accumbens shell guide cannulae and assigned to either a chronic intermittent ethanol vapor-exposure condition (to induce dependence) or an air-exposed control group. Following a one-month exposure period, nalmefene, nor-binaltorphimine (nor-BNI; selective for κ-opioid receptors) or a combination of the selective opioid receptor antagonists CTOP and naltrindole (selective for the μ- and δ-opioid receptors, respectively) were site-specifically infused into the nucleus accumbens shell prior to ethanol self-administration sessions during acute withdrawal. Nalmefene and CTOP/naltrindole dose-dependently reduced ethanol self-administration in nondependent and dependent animals, whereas nor-BNI selectively attenuated ethanol self-administration in ethanol-dependent animals without affecting the self-administration of nondependent animals. Further analysis indentified that intra-accumbens shell nalmefene was more potent in ethanol-dependent animals and that the increased potency was attributable to a κ-opioid receptor mechanism. These data support the concept that dysregulation of DYN/κ-opioid receptor systems contributes to the excessive self-administration observed in dependent animals and suggest that pharmacotherapeutics for ethanol dependence that target κ-opioid receptors, in addition to μ- and δ-opioid receptors, are preferable to those that target μ- and δ-opioid receptor mechanisms alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These effects may be mediated by the extended amygdala, including the CeA and shell of the NAc (Nealey et al., 2011).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Nealey et al., 2011
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Actual Causes of Death in the United States, 2000
Mokdad, A. H. (2004) · JAMA · doi:10.1001/jama.291.10.1238 · Cited by 5,211
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
The 1996 Guide for the Care and Use of Laboratory Animals
Clark, J. D., Gebhart, G. F., Gonder, J. C., Keeling, M. E., & Kohn, D. F. (1997) · ILAR Journal · doi:10.1093/ilar.38.1.41 · Cited by 4,429
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, S. P., Dufour, M. C., & Pickering, R. P. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.02.004 · Cited by 1,509
Dopamine and drug addiction: the nucleus accumbens shell connection
Di Chiara, G., Bassareo, V., Fenu, S., De Luca, M. A., Spina, L., Cadoni, C., Acquas, E., Carboni, E., Valentini, V., & Lecca, D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.032 · Cited by 935
Cited by
Sorted by citations
The Development and Maintenance of Drug Addiction
Wise, R. A., & Koob, G. F. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.261 · Cited by 617
Addiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483
Mann, K. F., Bladström, A., Torup, L., Gual, A., & van den Brink, W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.020 · Cited by 486
The dark side of emotion: the addiction perspective
Koob, G. F. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.044 · Cited by 433
Addiction is a Reward Deficit and Stress Surfeit Disorder
Koob, G. F. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00072 · Cited by 397
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Negative reinforcement in drug addiction: the darkness within
Koob, G. F. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.03.011 · Cited by 364
Addiction and Stress: An Allostatic View
Koob, G. F., & Schulkin, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.008 · Cited by 315
Uhl, G. R., Koob, G. F., & Cable, J. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13989 · Cited by 286
Neurocircuitry of alcohol addiction
Koob, G. F. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62619-6.00003-3 · Cited by 238
Nalmefene: A Review of Its Use in the Treatment of Alcohol Dependence
Keating, G. M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0101-y · Cited by 216
Influence of stress associated with chronic alcohol exposure on drinking
Becker, H. C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.028 · Cited by 191
Alcohol Dependence, Withdrawal, and Relapse
Becker, H. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405941-2.00019-5 · Cited by 188
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022) · Drugs · doi:10.1007/s40265-021-01670-3 · Cited by 169
Operant alcohol self-administration in dependent rats: Focus on the vapor model
Vendruscolo, L. F., & Roberts, A. J. (2014) · Alcohol · doi:10.1016/j.alcohol.2013.08.006 · Cited by 166
Escalation of drug self-administration as a hallmark of persistent addiction liability
Edwards, S., & Koob, G. F. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283644d15 · Cited by 151
The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors
Kissler, J. L., Sirohi, S., Reis, D. J., Jansen, H. T., Quock, R. M., Smith, D. G., & Walker, B. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.014 · Cited by 145
Self-citationMechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Rose, J. H., Karkhanis, A. N., Chen, R., Gioia, D., Lopez, M. F., Becker, H. C., McCool, B. A., & Jones, S. R. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv127 · Cited by 136
Existing and future drugs for the treatment of the dark side of addiction
Koob, G. F., & Mason, B. J. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103143 · Cited by 121
Schlosburg, J. E., Whitfield, T. W., Park, P. E., Crawford, E. F., George, O., Vendruscolo, L. F., & Koob, G. F. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1979-13.2013 · Cited by 119
Söderpalm, B., & Ericson, M. (2011) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-28720-6_170 · Cited by 120
Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence
Walker, B. M., Valdez, G. R., McLaughlin, J. P., & Bakalkin, G. Y. (2012) · Alcohol · doi:10.1016/j.alcohol.2011.10.006 · Cited by 107
Self-citationSmith, J. S., Schindler, A. G., Martinelli, E., Gustin, R. M., Bruchas, M. R., & Chavkin, C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2980-11.2012 · Cited by 102
The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety
Schank, J. R., Goldstein, A., Rowe, K. E., King, C. E., Marusich, J. A., Wiley, J. L., Carroll, F. I., Thorsell, A., & Heilig, M. A. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00455.x · Cited by 101
Mann, K. F., Torup, L., Sørensen, P. S., Gual, A., Swift, R. M., Walker, B. M., & van den Brink, W. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.10.008 · Cited by 101
Self-citationNeuroclinical Framework for the Role of Stress in Addiction
Kwako, L. E., & Koob, G. F. (2017) · Chronic Stress · doi:10.1177/2470547017698140 · Cited by 105
Endogenous opiates and behavior: 2006
Bodnar, R. J. (2007) · Peptides · doi:10.1016/j.peptides.2007.09.002 · Cited by 91
Wallace, C. W., & Fordahl, S. C. (2021) · Nutrition Research Reviews · doi:10.1017/s0954422421000196 · Cited by 98
George, O., Koob, G. F., & Vendruscolo, L. F. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3623-1 · Cited by 84
Neurochemical mechanisms of alcohol withdrawal
Becker, H. C., & Mulholland, P. J. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62619-6.00009-4 · Cited by 88
A systems medicine research approach for studying alcohol addiction
Spanagel, R., Durstewitz, D., Hansson, A. C., Heinz, A., Kiefer, F., Köhr, G., Matthäus, F., Nöthen, M. M., Noori, H. R., Obermayer, K., et al. (2013) · Addiction Biology · doi:10.1111/adb.12109 · Cited by 83
Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol
Anderson, R. I., & Becker, H. C. (2017) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13406 · Cited by 79
κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake
Whitfield, T. W., Schlosburg, J. E., Wee, S., Gould, A., George, O., Grant, Y., Zamora-Martinez, E. R., Edwards, S., Crawford, E., Vendruscolo, L. F., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1978-13.2015 · Cited by 75
Personalized Treatment of Alcohol Dependence
Kranzler, H. R., & McKay, J. R. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0296-5 · Cited by 74
Karkhanis, A. N., Huggins, K. N., Rose, J. H., & Jones, S. R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.022 · Cited by 68
Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders
Niciu, M. J., & Arias, A. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0096-4 · Cited by 74
Koob, G. F. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4484-6 · Cited by 73
Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system
SIROHI, S. K., Bakalkin, G. Y., & Walker, B. M. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00095 · Cited by 68
Self-citationBerger, A. L., Williams, A. M., McGinnis, M. M., & Walker, B. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.229 · Cited by 66
Self-citationKappa opioid regulation of anxiety-like behavior during acute ethanol withdrawal
Valdez, G. R., & Harshberger, E. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.019 · Cited by 63
Yardley, M. M., & Ray, L. A. (2016) · Addiction Biology · doi:10.1111/adb.12349 · Cited by 62
Endogenous opiates and behavior: 2011
Bodnar, R. J. (2012) · Peptides · doi:10.1016/j.peptides.2012.09.027 · Cited by 58
Dysregulation of brain stress systems mediates compulsive alcohol drinking
Tunstall, B. J., Carmack, S. A., Koob, G. F., & Vendruscolo, L. F. (2017) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.10.006 · Cited by 55
Williams, A. M., Reis, D. J., Powell, A. S., Neira, L. J., Nealey, K. A., Ziegler, C. E., Kloss, N. D., Bilimoria, J. L., Smith, C. E., & Walker, B. M. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2691-3 · Cited by 56
Self-citationSiciliano, C. A., Calipari, E. S., Yorgason, J. T., Lovinger, D. M., Mateo, Y., Jimenez, V. A., Helms, C. M., Grant, K. A., & Jones, S. R. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4239-4 · Cited by 53
Erikson, C. M., Wei, G., & Walker, B. M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.034 · Cited by 51
Self-citationHansson, A. C., Gründer, G., Hirth, N., Noori, H. R., Spanagel, R., & Sommer, W. H. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.010 · Cited by 55
Emerging pharmacotherapies for alcohol use disorder
Mason, B. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.032 · Cited by 47
Gillett, K., Harshberger, E., & Valdez, G. R. (2013) · Alcohol · doi:10.1016/j.alcohol.2013.05.001 · Cited by 46
Smith, A. C. W., Nealey, K. A., Wright, J. W., & Walker, B. M. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.04.011 · Cited by 44
Self-citationMontesinos, J., Gil, A., & Guerri, C. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13416 · Cited by 49
Nalmefene: a new approach to the treatment of alcohol dependence
Paillé, F., & Martini, H. (2014) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s45666 · Cited by 44
Laramée, P., Brodtkorb, T., Rahhali, N., Knight, C., Barbosa, C., François, C., Toumi, M., Daeppen, J., & Rehm, J. T. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005376 · Cited by 47
Koob, G. F., & Vendruscolo, L. F. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_424 · Cited by 46
Kissler, J. L., & Walker, B. M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.183 · Cited by 44
Self-citationDeehan, G. A., McKinzie, D. L., Carroll, F. I., McBride, W. J., & Rodd, Z. A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.006 · Cited by 44
Henricks, A. M., Berger, A. L., Lugo, J. M., Baxter-Potter, L. N., Bieniasz, K. V., Petrie, G. N., Sticht, M. A., Hill, M. N., & McLaughlin, R. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.023 · Cited by 42
Mu opioid receptors in GABAergic neurons of the forebrain promote alcohol reward and drinking
Hamida, S. B., Boulos, L., McNicholas, M., Charbogne, P., & Kieffer, B. L. (2017) · Addiction Biology · doi:10.1111/adb.12576 · Cited by 38
Opioid modulators for alcohol dependence
Hillemacher, T., Heberlein, A., Muschler, M. A. N., Bleich, S., & Frieling, H. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.592139 · Cited by 39
Neuroscience of opiates for addiction medicine
Zhou, Y., & Leri, F. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.09.001 · Cited by 37
Long-term ethanol effects on acute stress responses: modulation by dynorphin
Rácz, I., Markert, A., Mauer, D., Stoffel‐Wagner, B., & Zimmer, A. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00494.x · Cited by 38
An Animal Model of Alcohol Dependence to Screen Medications for Treating Alcoholism
Becker, H. C., & Lopez, M. F. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.02.006 · Cited by 35
Dynorphin and κ-Opioid Receptor Dysregulation in the Dopaminergic Reward System of Human Alcoholics
Bazov, I., Sarkisyan, D., Kononenko, O., Watanabe, H., Yakovleva, T., Hansson, A. C., Sommer, W. H., Spanagel, R., & Bakalkin, G. Y. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0844-4 · Cited by 34
Haun, H. L., Lebonville, C. L., Solomon, M. G., Griffin, W. C., Lopez, M. F., & Becker, H. C. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.01.002 · Cited by 34
Alcohol: A stimulant activating brain stress responsive systems with persistent neuroadaptation
Zhou, Y., & Kreek, M. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.044 · Cited by 34
Rose, J. L., Karkhanis, A. N., Steiniger‐Brach, B., & Jones, S. R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081216 · Cited by 32
Cross-Species Alterations in Synaptic Dopamine Regulation After Chronic Alcohol Exposure
Siciliano, C. A., Karkhanis, A. N., Holleran, K. M., Melchior, J. R., & Jones, S. R. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_106 · Cited by 32
Dissociable Effects of Kappa-Opioid Receptor Activation on Impulsive Phenotypes in Wistar Rats
Walker, B. M., & Kissler, J. L. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.129 · Cited by 25
Self-citationTigecycline Reduces Ethanol Intake in Dependent and Nondependent Male and Female C57 BL /6J Mice
Bergeson, S. E., Nipper, M. A., Jensen, J. P., Helms, M. L., & Finn, D. A. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13251 · Cited by 25
Zhou, Y., Colombo, G., Niikura, K., Carai, M. A. M., Femenía, T., García‐Gutiérrez, M. S., Manzanares, J., Ho, A., Gessa, G. L., & Kreek, M. J. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01867.x · Cited by 24
Jarman, S., Haney, A. M., & Valdez, G. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205016 · Cited by 22
Walker, B. M. (2012) · Alcohol · doi:10.1016/j.alcohol.2012.01.001 · Cited by 22
Self-citationGo, B. S., SIROHI, S. K., & Walker, B. M. (2019) · Addiction Biology · doi:10.1111/adb.12715 · Cited by 23
Self-citationHenricks, A. M., Berger, A. L., Lugo, J. M., Baxter-Potter, L. N., Bieniasz, K. V., Craft, R. M., & McLaughlin, R. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.032 · Cited by 22
Effect of chronic alcohol vapor exposure on reinstatement of alcohol seeking induced by U50,488
Funk, D. R., Coen, K. M., Tamadon, S., & Lê, A. D. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.017 · Cited by 22
Fontaine, H. M., Silva, P. R., Neiswanger, C., Tran, R., Abraham, A. D., Land, B. B., Neumaier, J. F., & Chavkin, C. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01178-0 · Cited by 24
Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
Cameron, C. M., Nieto, S. J., Bosler, L., Wong, M. H., Bishop, I., Mooney, L. J., & Cahill, C. M. (2021) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2021.10009 · Cited by 20
Calleja‐Conde, J., Echeverry‐Alzate, V., Giné, E., Bühler, K., Nadal, R. A., Maldonado, R. J., de Fonseca, F. R., Gual, A., & López‐Moreno, J. A. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13526 · Cited by 18
Zhou, Y., & Kreek, M. J. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.245621 · Cited by 19
Bazov, I., Sarkisyan, D., Kononenko, O., Watanabe, H., Karpyak, V. M., Yakovleva, T., & Bakalkin, G. Y. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0075-5 · Cited by 18
D’Addario, C., Shchetynsky, K., Pucci, M., Cifani, C., Gunnar, A., Vukojević, V. B., Padyukov, L., & Terenius, L. Y. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.012 · Cited by 17
Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol
Anderson, R. I., Moorman, D. E., & Becker, H. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_100 · Cited by 18
de Guglielmo, G., Simpson, S., Kimbrough, A., Conlisk, D., Baker, R., Cantor, M., Kallupi, M., & George, O. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109309 · Cited by 18
nor-BNI Antagonism of Kappa Opioid Agonist-Induced Reinstatement of Ethanol-Seeking Behavior
Harshberger, E., Gilson, E. A., Gillett, K., Stone, J. H., Amrani, L. E., & Valdez, G. R. (2016) · Journal of Addiction · doi:10.1155/2016/1084235 · Cited by 17
Drinking Levels and Profiles of Alcohol Addicted Rats Predict Response to Nalmefene
Foo, J. C., Vengeliene, V., Noori, H. R., Yamaguchi, I., Morita, K., Nakamura, T., Yamamoto, Y., & Spanagel, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00471 · Cited by 17
Alcohol and the dopamine system
Söderpalm, B., & Ericson, M. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.02.003 · Cited by 16
Wei, G., Sirohi, S., & Walker, B. M. (2022) · Addiction Biology · doi:10.1111/adb.13138 · Cited by 15
Self-citationLos Antagonistas de los Receptores Opioides en el Tratamiento del Alcoholismo
Serecigni, J. G. (2015) · Adicciones · doi:10.20882/adicciones.708 · Cited by 14
A conceptual framework for the intersection of hyperalgesia and hyperkatifeia in alcohol addiction
Koob, G. F., & Vendruscolo, L. F. (2025) · Alcohol · doi:10.1016/j.alcohol.2025.08.004 · Cited by 14
Nalmefene Hydrochloride: Potential Implications for Treating Alcohol and Opioid Use Disorder
Green, M., Veltri, C. A., & Grundmann, O. (2024) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s431270 · Cited by 15
The histone methyltransferase G9a mediates stress‐regulated alcohol drinking
Anderson, E. M., Lopez, M. F., Kastner, A., Mulholland, P. J., Becker, H. C., & Cowan, C. W. (2021) · Addiction Biology · doi:10.1111/adb.13060 · Cited by 13
Farahbakhsh, Z. Z., Song, K., Branthwaite, H. E., Erickson, K. R., Mukerjee, S., Nolan, S. O., & Siciliano, C. A. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01547-x · Cited by 13
Pirino, B. E., Kelley, A. M., Karkhanis, A. N., & Barson, J. R. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15078 · Cited by 13
Green, E. W., Byers, I. S., & Deutsch‐Link, S. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.09.017 · Cited by 14
Özkan-Kotiloğlu, S., Kaya-Akyüzlü, D., Yurdakul, R., Yıldırım, M. A., & İlhan, İ. Ö. (2023) · Alcohol and Alcoholism · doi:10.1093/alcalc/agad036 · Cited by 12
Accumbal μ‐Opioid Receptors Modulate Ethanol Intake in Alcohol‐Preferring Alko Alcohol Rats
Uhari-Väänänen, J. K., Raasmaja, A., Bäckström, P., Oinio, V., Airavaara, M., Piepponen, P. T., & Kiianmaa, K. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13176 · Cited by 14
Inhibition of Glyoxalase 1 reduces alcohol self-administration in dependent and nondependent rats
de Guglielmo, G., Conlisk, D., Barkley‐Levenson, A. M., Palmer, A. A., & George, O. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.03.001 · Cited by 11
Lepreux, G., Shinn, G. E., Wei, G., Suko, A. V., Concepcion, G., Sirohi, S., Go, B. S., Bruchas, M. R., & Walker, B. M. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109457 · Cited by 10
Self-citationTobin, S. J., Wakefield, D. L., Terenius, L. Y., Vukojević, V. B., & Jovanović‐Talisman, T. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00488 · Cited by 10
Metadata
- Authors
- Nealey, K. A., Smith, A. W., Davis, S. M., Smith, D. G., & Walker, B. M.
- Affiliations
- Washington State University (US)
- Lundbeck (United States) (US)
- Corresponding author
- Walker, Brendan M.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 61
- Issue
- 1-2
- Pages
- 35-42
- ISSN
- 0028-3908 (ISSN-L)
- PMC
- PMC3955175
- OpenAlex
- W2054879676
- Cited by
- 133
- References
- 66
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 4 · 2023: 7 · 2022: 7 · 2021: 7 · 2020: 2 · 2019: 5 · 2018: 13 · 2017: 11 · 2016: 15 · 2015: 11 · 2014: 9 · 2013: 15 · 2012: 14
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (R01AA020394)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- kappa opioid receptor, nalmefene, ethanol dependence, nucleus accumbens shell, dynorphin, nor-binaltorphimine, CTOP, naltrindole, ethanol self-administration, ethanol withdrawal, opioid antagonists
- MeSH terms
- Ethanol, Alcoholism, Animals, Male, Naltrexone, Nucleus Accumbens, Self Administration, Rats, Wistar, Receptors, Opioid, kappa, Rats, Infusions, Intraventricular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review